(1 - 7 from 7
)
3D Organoids: unmasking mechanisms of resistance and accelerating ...www.vhio.net d-organoids-unmasking-mechanisms-of-resistance-and-accelerating-p...
vhio.net
Allocating a total of €8 million to support these endeavors, among AECC´s awardees for is VHIO´s Guillem Argilés, Physician Scientist of ...
More flexible dose of regorafenib to relieves side-effects in mCRC...
coloproctologynews.net
Guillem Argilés (Credit: VHIO). Medical oncologists administer anticancer drug regorafenib to try to improve overall survival in patients with ...
Novel bispecific antibody alone or with PD1 promises increased ...
ecancer.org
Study authors, also including Guillem Argilés, Medical Oncologist and physician-scientist of VHIO´s Gastrointestinal and Endocrine Tumors ...
sorted by relevance / date